SCHEMBL27776809

SCHEMBL27776809

Cc1cccc2c1-c1c(C)cccc1C2C=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.37
TSHR P16473 2/20 0.37
HTR2C P28335 7/20 0.37
HTR2A P28223 3/20 0.37
HTR2B P41595 3/20 0.37
CA1 P00915 3/20 0.33
CA2 P00918 3/20 0.33
CA7 P43166 2/20 0.33
CA9 Q16790 2/20 0.33
CYP1A2 P05177 2/20 0.33
MYC P01106 1/20 0.33
CD44 P16070 1/20 0.33
CYP2A6 P11509 1/20 0.33
ACHE P22303 1/20 0.32
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
MAPT P10636 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
PBRM1 Q86U86 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11464929 0.74 TSHR (0.37) ALDH1A1TSHRHTR2CACHEMAPT
SCHEMBL7754656 0.73 MEN1 (0.38) ALDH1A1TSHRCA1CA2CYP2A6
SCHEMBL11473460 0.71 ACHE (0.37) ALDH1A1CYP1A2CYP2A6ACHEGAA
Iodide SCHEMBL11463652 0.71 MEN1 (0.36) ALDH1A1CYP2A6CYP3A4MAPTHPGD
Hydrochloric Acid SCHEMBL11465934 0.71 MEN1 (0.36) ALDH1A1HTR2CCYP2A6CYP3A4MAPT
SCHEMBL28618542 0.70 HTR2B (0.46) ALDH1A1TSHRHTR2CHTR2AHTR2B
SCHEMBL30838752 0.70 HTR2B (0.46) ALDH1A1TSHRHTR2CHTR2AHTR2B
SCHEMBL11465719 0.70 TSHR (0.37) ALDH1A1TSHRHTR2CCYP1A2ACHE
Hydrochloric Acid SCHEMBL11474712 0.69 ACHE (0.36) ALDH1A1HTR2CCYP1A2CYP2A6ACHE
SCHEMBL9622137 0.68 MYC (0.44) ALDH1A1TSHRHTR2CHTR2AHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101616892-A The tricyclic compound that is used for the treatment of the iron imbalance XENON PHARMACEUTICALS INC 2009-12-30 CN disclosed